We obtained fibroblasts from a female PD patient carrying a PINK1 I368N mutation (PINK1 cells) as well as isogenic fibroblasts in which this mutation was corrected to the PINK1 wild-type version by using CRISPR technology (control cells). This evidence concerns the gene PINK1 and Parkinson disease.